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Abstract
Background. Macrophage migration inhibitory factor (MIF) was originally described as a cytokine that inhibits migration of
macrophages at the site of inﬂammation. Subsequently it was also identiﬁed as a stress-induced hormone released from the
anterior pituitary lobe in response to some pro-inﬂammatory stimuli like endotoxins and tumour necrosis factor (TNF-a).
Aim. To compare postoperative changes in serum MIF levels of patients undergoing bowel and liver resections. It has clinical
relevance to describe the kinetics of this crucial mediator of systemic inﬂammation in surgery.
Methods. A total of 58 patients were studied over 4 years. Group A (28 patients) underwent only hepatic resection without
enterotomy. Group B (30 patients) had bowel resection with enterotomy. MIF, IL-1b, IL-8, prealbumin, albumin,
a1-glycoprotein, ﬁbrinogen, and C-reactive protein levels were measured preoperatively, immediately following surgery,
and postoperatively for three consecutive days. To evaluate organ functions, multiple organ dysfunction score was used.
Results. A signiﬁcantly higher level of MIF (4,505 pg/mL) was found in group A when compared to that of group B immediately
following surgery. Other parameters monitored in this study were not statistically different between the two groups.
Conclusion. Higher elevations in MIF levels with liver resections, compared to bowel resections, might be attributable to MIF
release from damaged liver cells. The presumably minimal endotoxin exposure during bowel surgery was either insufﬁcient or
inefﬁcient to induce relevant MIF elevations in our patients. To fully delineate implications of this ﬁnding further studies are
needed.
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Introduction
Macrophage migration inhibitory factor (MIF) was
the ﬁrst representative of potent immunomediator
cytokines that have been described from the begin-
ning of the 1960s (1). Its release from activated
T lymphocytes was ﬁrst considered as its sole source,
and its action was thought to be limited to prevention
of macrophage migration away from the site of in-
ﬂammation. MIF is now considered to be a stress-
induced cytokine hormone produced by several
immune cell types, as well as by the anterior pituitary
gland, and its most important role is in the counter-
regulation of the anti-inﬂammatory effects of gluco-
corticoids (2).
The stress-induced MIF secretion from the
adenohypophysis is primarily increased by pro-
inﬂammatory stimuli, i.e. endotoxin, tumour necrosis
factor, and also by glucocorticoids (3).
In-vivo models have shown that the level of hypo-
physeal MIF fell signiﬁcantly after intraperitoneal
lipopolysaccharide injection accompanied by an
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levels in the serum (4). An interesting study showed
that endotoxin-related mortality was increased by
MIF in mice, while administration of anti-MIF anti-
bodies revealed the contrary (5). In hypophysec-
tomized mice Calandra et al. attributed bacterial
infection-induced MIF production primarily to
macrophages (6). A systematic analysis of MIF
expression following administration of lipopoly-
saccharide revealed that within 6 hours of bacterial
inoculation MIF production increased not only in the
pituitary and the macrophages, but also in the lungs,
adrenal glands, spleen, and the liver of rats (7).
Clinical studies have shown that MIF has a primary
role in endotoxaemia-induced toxic reactions, in
sepsis (8), and acute respiratory distress syndrome
(ARDS) (9). In critically ill patients, suffering from
septic shock, an increased level of MIF was found, but
this was lower in the survivors compared to the non-
survivors (10). Surgical trauma is associated with
an increased level of adrenocorticotropic hormone
(ACTH) and cortisol (11). In patients suffering
from blunt trauma MIF levels were higher in the
non-survivor than in the survivor groups (12). Even
higherserumlevelsofMIFwerefoundbySatoshietal.
in patients undergoing liver resection for treatment
of hepatic neoplasm (13).
In our prospective, descriptive clinical study we
investigated the changes of MIF levels and other
indicators of systemic inﬂammation in patients under-
going bowel resection with presumably higher endo-
toxin levels (14,15), compared with patients having
hepatic resection without enterotomy. Based on
our hypothesis, we expected a signiﬁcant increase
in MIF levels in both groups. Following that, we
correlated it with early postoperative morbidity and
mortality.
Methods
Patients
Following the approval of the local ethical committee,
58 patients were studied between October 2004
and December 2008. Group A included cancer
patients who had liver resection without enterotomy
(28 patients). In group B, patients underwent bowel
resection with enterotomy (30 patients). Based on our
exclusion criteria, patients undergoing emergency
operations without bowel preparation, inoperable
carcinoma, and patients with chronic organ failure
based on acute physiology and chronic health evalu-
ation (APACHE II) scores were excluded from the
investigation.
Methods
In all the patients, anaesthesia was induced with
propofol (2 mg/kg) and fentanyl (0.15 mg/kg); muscle
relaxation was achieved with atracurium (0.5 mg/kg,
then 0.1 mg/kg in repeated boluses pro re nata).
Anaesthesia was maintained with sevoﬂurane in a
N2O/O2 2:1 mixture. Prior to surgery an epidural
catheter was placed, under local anaesthesia, in accor-
dance with the dermatomes of the operative site to
administer 0.2% ropivacaine and fentanyl (5 mg/mL)
in a continuous epidural infusion. Both groups
received a single i.v. dose of prophylactic antibiotics,
cefuroxime and metronidazole (1.5 g and 0.5 g, res-
pectively). The levels of MIF, tumour necrosis factor
(TNF-a), interleukin (IL)-lb, IL-8, prealbumin,
albumin, ﬁbrinogen, and C-reactive protein (CRP)
were preoperatively documented at 60 minutes prior
to the procedures (T0), postoperatively at 60 minutes
immediately after the surgery (T1), and on three
consecutivepostoperativedays at 24, 48, and 72hours
respectively (T2, T3, T4). To evaluate disease pro-
gression and the extent of organ failure the multiple
organ dysfunction score (MODS) elaborated by
Marshall et al. (16) that considers the functional
parameters of six organ systems was used. The score
was determined on admission and later in the ﬁrst
3 days. Performance of the respiratory system was
assessed by the PaO2/FiO2 ratio, and for the cardio-
vascular system the pulse rate (P), the central venous
pressure (CVP), and the mean arterial pressure
(MAP) were monitored. Hepatic and renal functions,
along with the haematopoietic system, were evaluated
from the serum bilirubin, creatinine levels, and the
platelet count, respectively. Central nervous system
(CNS) function was assessed with the Glasgow coma
scale. MODS, which ranges between normal function
(0points) and severe multiorgan failure (4–20 points),
was calculated as a sum of the individual organ
functions.
Cytokine assays
Serum MIF levels were measured by an enzyme-
linked immunosorbent assay (ELISA) with a Duo set
ELISA development system from R&D Systems,
Minneapolis, USA, according to manufacturer’s
instructions.Everysamplewasdilutedintherespective
ELISA assay buffer. Serum IL-1b, IL-8, and TNF-a
were determined by an automated chemiluminescent
immunoassayanalyser,DPC(nowSiemens)Immulite
1000, Deerﬁeld, USA. For procalcitonin assays, the
immunochemiluminescent kit of BRAHMS Diagnos-
tica, Berlin, Germany was used in a Berthold LB
Inﬂammatory markers in abdominal surgery 1259507 luminometer with two programmable injectors.
Albumin levels were measured by the bromo-cresol-
green dye bindingmethod(Hitachi 917, Roche),while
prealbumin and a1-glycoprotein concentrations were
assayed by immunoturbidimetry (Hitachi 704, Orion-
Pharma). C-reactive protein concentrations were
determined using a Beckman Immage nephelometer.
Plasma ﬁbrinogen levels were assayed by direct deter-
mination of ﬁbrinogen (System CA 1500) using Stago
thrombin reagent.
Statistical analysis
The data are shown in median and interquartile
ranges. The statistical analysis was carried out using
the Statistical Program for Social Sciences for Win-
dows(SPSS),usingMann-WhitneyandKolmogorov-
Smirnov and analysis of variance (ANOVA). The
correlation of the two variables was tested using
Spearman’s rank correlation analysis. The temporal
changes of the examined parameters were analysed by
the Wilcoxon test. The level of signiﬁcance was set at
P < 0.05.
Results
The demographic characteristics of the patients and
the details of the operations are summarized in
Table I. The average duration of the surgical proce-
dure was signiﬁcantly longer in group B compared to
that of group A. There were no differences concerning
intraoperative transfusions.
Macrophage migration inhibitory factor
In both groups the MIF preoperative values (MIF0)
were found to be within the normal range, and there
was no signiﬁcant difference between the two groups.
ImmediatelyfollowingsurgerytheMIFvalues(MIF1)
measured in those patients undergoing hepatic resec-
tion were signiﬁcantly higher (4,505 pg/mL) com-
pared to the bowel resection group (1,774 pg/mL)
shown in Table II. On the ﬁrst postoperative day
normal values of MIF were measured in both groups,
and these values did not change on the second or the
third postoperative days as shown in Figure 1.
Procalcitonin
On the ﬁrst postoperative day, both groups showed
higher procalcitonin levels (PCT2) than the values
reported in literature (17). It slowly declined on
subsequent days (PCT3, PCT4), but these changes
were not signiﬁcant compared to the initial values in
these groups.
Tumour necrosis factor
In group A the average TNF-a level was found to
increase moderately but gradually; on day 3 decreased
levels were observed in group A: TNF-a0: 5.1 pg/mL
(4–19 pg/mL); TNF-a3: 8.5 pg/mL (4.9–9.32 pg/
mL). In group B, there was also a gradual increase,
with highest levels on day 3: TNF-a0: 5.1 pg/mL
(4–6 pg/mL); TNF-a3: 8.9 pg/mL (7.3–16.2 pg/mL).
No signiﬁcant difference was found between the two
groups concerning daily TNF-a levels. No correla-
tion was observed in groups A and B between the high
MIF1 and TNF-a levels.
Table I. Demographic data of patients and multiple organ
dysfunction scores (MODS) in the two groups.
Group A
(n = 28)
Group B
(n = 30) P
Age (years) 53 (34–65) 63 (22–77) NS
Gender (M/F) 19/11 21/7 NS
Duration of
operation (min)
160 (90–270) 240 (60–440) <0.001
Body weight (kg) 71 (54–85) 80 (63–118) NS
Height (cm) 169 (154–183) 173 (160–194) NS
MODS preoperatively
(T0)
2( 1 –3) 2 (1–3) NS
MODS postoperatively
(T1)
2( 1 –3) 1 (1–3) NS
MODS day 1 (T2) 2 (1–3) 1 (1–3) NS
MODS day 2 (T3) 2 (1–3) 2 (1–3) NS
MODS day 3 (T4) 2 (1–4) 3 (0–3) NS
Our data are presented as median (interquartile range). For the
statistical analyses the Mann-Whitney test was used. The duration
of operation was signiﬁcantly higher in group B.
Table II. Macrophage migration inhibitory factor (MIF) values in
the two groups.
Groups Group A Group B ANOVA P
MIF0 1137.87 ± 741.53 1462.94 ± 1276.49 NS
MIF1 4505.87 ± 551.72 1774.13 ± 1125.39 0.001
MIF2 1661.75 ± 869.88 1506.28 ± 1097.42 NS
MIF3 1558.50 ± 1113.55 1490.97 ± 1358.18 NS
MIF4 1302.33 ± 741.25 996.24 ± 913.85 NS
Values are means ± SD. For the statistical analyses the ANOVA test
was used.
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In the ﬁrst 24 hour the CRP level was within the
normal range (CRP0, CRP1), but all subsequent
values fell in the pathological range (CRP2, CRP3,
CRP4).
Other parameters
In both groups a gradual decrease of albumin and
prealbumin levels were observed without signiﬁcant
difference between groups. Similarly, no signiﬁcant
difference was observed regarding the IL-lb, IL-8,
a1-glycoprotein, and ﬁbrinogen levels.
Organ dysfunctions
Data obtained with MODS are summarized in
Table I. There was no statistically signiﬁcant differ-
ence between the two groups.
There was no correlation between MIF levels
and early postoperative morbidity and mortality
(Spearman’s rho = 0.21; P = 0.24).
Discussion
Sympathetically activated stress reactions might con-
tribute to multi-organ failure in the postoperative
period of major abdominal operations. In the patho-
genesis of this process, pro-inﬂammatory cytokines
(TNF-a, IL-1, IL-6) along with systemic endotox-
aemia may play a pivotal role. The secretion of MIF
has been shown to induce production of these critical
pro-inﬂammatory cytokines and has been detected in
several organs. The main sites of MIF production
are the immune cells, i.e. monocytes, macrophage-
activated T lymphocytes, and also the anterior pitu-
itary. The most frequent causes of MIF release are
pro-inﬂammatory stimuli, especially endotoxins,
TNF-a, and interferon-g. Systemic endotoxaemia
may follow complement-driven systemic activation
of the inﬂammatory cascade that damages the micro-
circulation, leading to ischaemia and reperfusion inju-
ries, and may also emerge from bacterial translocation
due to tissue hypoperfusion of the bowel wall.
In our prospective, descriptive study we assessed
the induction of macrophage migration inhibitory
factor levels in cancer patients undergoing bowel
resection (elective enterotomy) in comparison with
cancer patients undergoing liver resection (without
enterotomy). Gando et al. reported the highest MIF
levels at 24 hours following hepatolobectomy, and
this was explained by stress-induced hypothalamo-
hypophyseal activation and also by the liberation of
endotoxins (13). In our study, in group A, a signif-
icantly higher level of MIF was detected immediately
after the procedures that normalized on the ﬁrst
postoperative day. No association was observed bet-
ween elevated MIF levels and early postoperative
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Figure 1. Serum MIF levels preoperatively (MIF0), immediately postoperatively (MIF1), and on the three consecutive days (MIF2, MIF3,
MIF4). The data were plotted as a ‘box plot’. The minimum–maximum and interquartile ranges are shown on the ﬁgure. The difference in the
two groups was veriﬁed by the Mann-Whitney U test. *P < 0.006.
Inﬂammatory markers in abdominal surgery 127complications. There was no correlation of immediate
postoperatively elevated MIF levels with the kinetics
of cytokines and acute phase proteins measured
in this study. It has been reported that the most
effective stimulus of PCT release is bacterial endo-
toxin, hence similar PCT levels of the groups here
might reﬂect comparable endotoxin exposure (17).
The surgical stimulus activates the hypothalamo-
hypophyseal-adrenal system, resulting in increased
plasma ACTH, glucocorticoid, and MIF levels
(18). With the help of immunohistochemical analysis,
MIF has been expressed in hepatocytes in the areas
extending out from the central veins to the portal
tracts (19). Hira et al. have shown MIF expression to
play a crucial role in hepatocellular carcinoma (20).
Consistent with the notion, since both of our exper-
imental groups comprised cancer patients and the
preoperative MIF values did not differ, we assume
that highly elevated immediately postoperative
MIF levels of patients undergoing liver resection
are explained by tissue damage-related release of
MIF from hepatocytes rather than by inﬂammatory
stimulus-driven secretion. This hypothesis is further
supported by our ﬁndings that the operations lasted
signiﬁcantly longer in group B, hence we assumed
that the inﬂammatory response is greater and the MIF
secretion was signiﬁcantly lower. Despite the longer
operation time, the surgical insult corresponded well
in the two groups, therefore a similar increase of the
PCT and TNF-a levels, in accordance with previous
reports including ours, could be attributed to surgical
tissue damage (17,21). Our study was limited to a
certain extent by the unavailability of the liver func-
tion tests, but it serves as a pilot investigation for
further studies to delineate the postoperative kinetics
of MIF in different surgical procedures.
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